Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




3D-Printed Heart Valve Models Mimic Physiology

By LabMedica International staff writers
Posted on 17 Jul 2017
Cardiovascular disease researchers used an advanced multi-material three-dimensional printing technique to create patient-specific heart valve models that mimic the physiological qualities of human valves.

Investigators at the Georgia Institute of Technology (Atlanta, USA) had shown previously that a metamaterial three-dimensional printing technique could be used to create patient-specific phantoms that mimicked the mechanical properties of biological tissue. More...
In the current study, they aimed to use this methodology to develop a procedure simulation platform for in vitro transcatheter aortic valve replacement (TAVR). In addition, they evaluated the feasibility of using these three-dimensional printed mimics to quantitatively predict the occurrence, severity, and location of any degree of post-TAVR paravalvular leaks (PVL).

In conducting this retrospective study involving 18 patients who had undergone TAVR, patient-specific aortic root mimics were created using the three-dimensional printing technique combined with pre-TAVR computed tomography. CoreValve (self-expanding valve) prostheses were deployed in the mimics to simulate the TAVR procedure, from which post-TAVR aortic root strain was quantified in vitro. A novel index, the annular bulge index, was measured to assess the post-TAVR annular strain unevenness in the mimics.

Results published in the July 7, 2017, online edition of the journal JACC: Cardiovascular Imaging revealed that the maximum annular bulge index was significantly different among patient subgroups that had no PVL, trace-to-mild PVL, and moderate-to-severe PVL. Compared with other known PVL predictors, bulge index was the only significant predictor of moderate-severe PVL. Thus, in this proof-of-concept study, the investigators demonstrated the feasibility of using three-dimensional printed tissue-mimics to quantitatively assess post-TAVR aortic root strain in vitro.

"These three-dimensional printed valves have the potential to make a huge impact on patient care going forward," said contributing author Dr. Chuck Zhang, professor of industrial and systems engineering at the Georgia Institute of Technology. "Previous methods of using three-dimensional printers and a single material to create human organ models were limited to the physiological properties of the material used. Our method of creating these models using metamaterial design and multi-material three-dimensional printing takes into account the mechanical behavior of the heart valves, mimicking the natural strain-stiffening behavior of soft tissues that comes from the interaction between elastin and collagen, two proteins found in heart valves."

Related Links:
Georgia Institute of Technology


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.